Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
1.980
-0.060 (-2.94%)
At close: Aug 1, 2025, 4:00 PM
1.960
-0.020 (-1.01%)
After-hours: Aug 1, 2025, 6:29 PM EDT
Revance Therapeutics Market Cap
Jaguar Health has a market cap or net worth of $2.62 million as of August 1, 2025. Its market cap has decreased by -88.88% in one year.
Market Cap
2.62M
Enterprise Value
35.27M
1-Year Change
-88.88%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since October 5, 2018, Jaguar Health's market cap has decreased from $13.36M to $2.62M, a decrease of -80.37%. That is a compound annual growth rate of -21.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.62M | -77.99% |
| Dec 31, 2024 | 11.92M | 55.07% |
| Dec 29, 2023 | 7.68M | -41.52% |
| Dec 30, 2022 | 13.14M | -72.54% |
| Dec 31, 2021 | 47.85M | -44.06% |
| Dec 31, 2020 | 85.54M | 619.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |